- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06729424
"Living an Active Life with Osteoporosis" - a Digital Patient Education Program on Osteoporosis. a Feasibility/pilot Study As Part of the PATOS Project (Patient Education in Osteoporosis). (PilotPATOS)
In this feasibility and pilot study, the investigators aim to evaluate the effectiveness and safety of a digital patient education program for individuals with osteoporosis. The study involves a 5-week intervention period during which participants will have access to the digital education program. Patients will be assessed both before and after the intervention.
The digital patient education program comprises eight modules covering essential topics related to osteoporosis self-care. The program includes both psychoeducation and support for behavioral changes. Patients will progress through the program at their own pace.
The name of the digital patient education program is: program is: "Att leva ett aktivt liv med benskörhet" (translated to english "Living an Active Life with Osteoporosis")
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden, 58183
- Linkoping University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Osteoporosis diagnosis with or without a previous low-energy fracture
- Age > 50 years
- Women and men
- Basic computer skills
Exclusion Criteria:
- Patients with difficulty understanding the Swedish language to the extent that they cannot comprehend the content of the patient education program.
- Cognitive impairment/dementia where the patient is not deemed to understand the implications of study participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Digital patient education program
Digital patient education program for 5 weeks
|
The education consists of 8 modules including main themes within osteoporosis, with content aiming to promote behavioural changes including psychoeducation and behavioural activation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-related quality of life (HRQoL) - generic
Time Frame: 6 weeks
|
Assessed with RAND-36 (Research and Development questionnaire).
The RAND-36 compromises 36 items with two to six response options according to an ordinal scale.
Eight health domains are assessed, coded, scored and summarised to derive the domains.
The scores are transformed into a 0-100 scale.
Zero indicates the worst possible HRQoL and 100 the best.
|
6 weeks
|
|
Health-related quality of life (HRQoL) - generic
Time Frame: 6 weeks
|
Assessed with EQ-5D-5L.
The EQ5D covers 5 dimensionsand.
In addition to these dimensions, the EQ-5D includes a visual analogue scale (VAS) where respondents rate their overall health on a scale.
|
6 weeks
|
|
Self-Care in osteoporosis
Time Frame: 6 weeks
|
Assessed with 26 questions in 5 domains (medication, diet, physical training, fall risk, ergonomy).
Questions covering knowledge, motivation, opportunities and behaviour.
|
6 weeks
|
|
Patient enablement instrument (PEI)
Time Frame: 6 weeks
|
The patient enablement instrument (PEI) is used to measure the patient's perceived change in ability to understand and cope with his or her health issues after the treatment period and contains six items.
The text "As a result of the participating in the Osteoporosis School, do you feel that you are …" is followed by six items; 1) able to cope with life, 2) able to understand your illness, 3) able to cope with your illness, 4) able to keep yourself healthy, 5) confident about your health, and 6) able to help yourself.
The following five alternative answers were used for each statement; much better/much more, better/more, same, less/worse and not applicable.
The PEI point for much better/much more is 2; for better/more is 1; and for same, less/worse or not applicable is 0. These points are added and thus the total PEI score ranges between 0 (worst score) and 12 (best score).
|
6 weeks
|
|
Fear of falling
Time Frame: 6 weeks
|
Assessed with Falls Efficacy Scale-International (FES-I).
The FES-I is a 16-item questionnaire used to measure the level of concern about falling during social and physical activities inside and outside the home.
Each item I scored on a 4-point Likert scale ranging from (1 = not concerned, and 4= very concerned).
The item scores are summed up to a total score ranging from minimum 16 to maximum 64 with higher the score higher being the concern for falling.
|
6 weeks
|
|
Fear avoidance beliefs regarding physical activity
Time Frame: 6 weeks
|
The Fear-Avoidance Beliefs Questionnaire physical activity subscale (FABQ_FA) include 4 questions about physical activity.
Agreement with each statement is rated on a 7-point Likert Scale (0= completely disagree, to 6= completely agree), and a total score is calculated (maximum of 24) with higher scores indicates stronger fear avoidance beliefs.
|
6 weeks
|
|
Illness perception
Time Frame: 6 weeks
|
Assessed with the Brief-Illness Perception Questionnaire BIPQ which is an 8-item questionnaire that assesses cognitive and emotional representation of illness.
Each item is rated on a 0-10 scale with higher scores indicating a more threatening perception of the illness.
The total score is calculated by summing the scores and range between 0-80 with higher scores indicate worse illness perception.
|
6 weeks
|
|
Self-reported physical activity, alcohol consumption and smoking
Time Frame: 6 weeks
|
The questionnaire (Hälsobladet) is used in clinical routine in Sweden to assess self-reported lifestyle habits on a weekly basis
|
6 weeks
|
|
Self-reported pain and intake of pain medication
Time Frame: 6 weeks
|
Self-reported pain was assessed both regarding intensity (NRS 0-10) and frequency as well as medication intake.
|
6 weeks
|
|
Self-reported fall and balance
Time Frame: 6 weeks
|
Self-reported fall during the last year as well as perceived balance was assessed (NRS 0-10)
|
6 weeks
|
|
Maximal walking speed
Time Frame: 6 weeks
|
Walking speed was assessed with patients walking 10 meters at a maximal walking speed.
|
6 weeks
|
|
Hand-strength
Time Frame: 6 weeks
|
Assessed in sitting position with the Jamar both right and left side.
|
6 weeks
|
|
Chair Sit to stand (30 sec)
Time Frame: 6 weeks
|
The maximal number of sit to stand during 30 seconds.
|
6 weeks
|
|
Measure of hyperkyfosis
Time Frame: 6 weeks
|
With patients in upright standing distance between C7 and wall, as well as between tragus of the ear to wall was evaluated.
|
6 weeks
|
|
Timed-loading standing test
Time Frame: 6 weeks
|
Ability to stand up with weights (1-0.5 kg) in both arms during a maximum of 2 minutes
|
6 weeks
|
|
One-leg standing with eyes opened
Time Frame: 6 weeks
|
Assessed for both right and left legs and a maximum of 60 seconds
|
6 weeks
|
|
One-leg standing with eyes closed
Time Frame: 6 weeks
|
Assessed for both right and left legs and a maximum of 60 seconds.
|
6 weeks
|
|
Walking on a line
Time Frame: 6 weeks
|
Patients were asked to take a maximum of 15 steps forward on a line and then a maximum of 15 steps backwards on a line.
|
6 weeks
|
|
Timed-up and go (TUG)
Time Frame: 6 weeks
|
Patients were asked to stand up from sitting and walt 3 meters, turning around, walk back and sit again.
Time was measured in seconds.
|
6 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Activity Pattern
Time Frame: 6 weeks
|
Activity pattern will be measured with activPAL™ in a subset of patients (n=10).
The activPAL™ will be used recording physical activities during 7 days (including time spent lying, sitting, standing and stepping).
|
6 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PilotPATOS
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoporosis
-
Radius Health, Inc.CompletedOsteoporosis | Osteoporosis Risk | Osteoporosis, Postmenopausal | Osteoporosis Fracture | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of Vertebrae | Osteoporosis VertebralUnited States
-
Radius Health, Inc.CompletedOsteoporosis | Age Related Osteoporosis | Osteoporosis, Age-Related | Osteoporosis Localized to Spine | Osteoporosis Senile | Osteoporosis of VertebraeUnited States, Poland, Italy
-
National Taiwan University HospitalRecruitingOsteoporosis | Osteoporosis PostmenopausalTaiwan
-
Hoffmann-La RocheCompletedPostmenopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States, Puerto Rico
-
Appalachian State UniversityNorth Carolina Agriculture & Technical State UniversityCompletedPostmenopausal Osteoporosis | Osteoporosis, OsteopeniaUnited States
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruitingPost Menopausal OsteoporosisFrance
-
AmgenCompletedPost Menopausal OsteoporosisFrance
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisUnited States
-
Hoffmann-La RocheCompletedPost Menopausal OsteoporosisSpain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
Clinical Trials on Digital patient education program
-
Göteborg UniversityRecruitingFunctional Abdominal Pain SyndromeSweden
-
St. Olavs HospitalNorwegian University of Science and TechnologyRecruitingMental Disorder | Patient Education | Mental Health IssueNorway
-
Umeå UniversityVästerbotten County Council, SwedenRecruitingRadiography | DentistrySweden
-
University of MalayaRecruiting
-
Giresun UniversityRecruitingDigital Literacy | Digital Privacy | Online Privacy AwarenessTurkey (Türkiye)
-
Udayana UniversityNot yet recruitingAsthma | Asthma in Children | Asthma ChronicIndonesia
-
Hospices Civils de LyonCompletedHypermobility Type Ehlers-Danlos SyndromeFrance
-
Oslo Metropolitan UniversityUniversity of OsloCompletedRenal RecipientsNorway
-
Wen-Shao LinNational Taipei University of Nursing and Health Sciences; Cheng Hsin Rehabilitation...Active, not recruitingScleroderma, SystemicTaiwan
-
Karolinska InstitutetCompletedFunctional Gastrointestinal DisordersSweden